Neptune Insurance
- Market cap
- 3.82B
- P/E (TTM)i
- 102.05
- P/Bi
- -17.21
- EPSi
- -0.20
- Div yieldi
- 0.00%
- 52W posi
- 64%
Anonymous reader poll. Unscientific, not investment advice.
Valuation each multiple against its own 5-year range
Vs. peers Insurance Brokers
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Neptune Insurance (NP) | 3.82B | 102.05 | -17.21 | 0.00% |
| Marsh (MRSH) | 82.87B | 21.20 | 5.46 | 2.07% |
| Arthur J. Gallagher (AJG) | 58.21B | 37.66 | 2.45 | 1.19% |
| Aon PLC (AON) | 57.37B | 14.91 | 5.98 | 1.13% |
| Willis Towers Watson (WTW) | 27.00B | 18.00 | 3.51 | 1.29% |
| Brown & Brown (BRO) | 20.65B | 19.72 | 1.64 | 1.05% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 19.8% above Morningstar's fair value estimate.
Fair value
Neptune Insurance Holdings Inc is assigned a 2-star quantitative star rating, reflecting our opinion that this share class is a somewhat unattractive choice, and investors should look elsewhere for more fruitful opportunities. The stock currently trades at a 21% premium over our quantitative fair value estimate of $22.34 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating. We require the price/fair value ratio to move a certain amount before the star rating can change. This stability-enhancing buffer is in effect for this stock.
The firm's valuation metrics undermine our estimated fair value. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of -5.9%, which sits in the bottom 10% compared with global peers. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which contributes to our view that shares are overvalued.
The firm's lack of profitability is an additional cause for concern. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. The firm's sales yield of 6.1%, for example, falls in the bottom 10% compared with global peers. This company's inability to generate significant sales growth without meaningful capital investment is a challenge, which further promotes our unfavorable price/fair value ratio.
In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.
Economic moat
The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.
By Quantitative Equity Report
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.